AL (immunoglobulin light chain) amyloidosis is a rare disease that often results in progressive organ dysfunction, organ failure and eventual death. Clonal plasma cells in the bone marrow secrete free ...
MSK cellular therapist Dr. Heather Landau led a phase 1 clinical trial showing CAR T cell therapy is effective against relapsed or resistant AL amyloidosis. “I’ve seen very sick patients have an ...
One of the most serious complications of rheumatologic and autoimmune diseases can be prevented with biologic drugs, a single-center chart review suggested, and some such products may be more ...
Amyloidosis Clinic Opens in Utah, Third in the Country Specializing in Treatment of the Rare Disease
(SALT LAKE CITY)— University of Utah Health Care has opened one of only three clinics nationwide and the only one of its kind in the Intermountain West, designed to cater to the needs of patients with ...
In their study published in the Mayo Clinic Proceedings, UAB researchers collaborated with researchers from Weill Cornell Medicine and Columbia University to show that carpal tunnel syndrome preceded ...
A patient-administered injection to treat hereditary transthyretin-mediated amyloidosis (ATTRv amyloidosis) has been recommended for routine NHS use in England. The National Institute for Health and ...
Top line results from a phase 3 trial of vutrisiran (Amvuttra), a new drug from Alnylam for the treatment of transthyretin-mediated amyloidosis with cardiomyopathy, are positive, according to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback